Fundación Pública Gallega de Medicina Genómica
Centro de investigación
Universidad de Extremadura
Badajoz, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Extremadura (7)
2024
-
Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
Pharmacological Research, Vol. 200
2021
2016
-
Progress in pharmacogenetics: Consortiums and new strategies
Drug Metabolism and Personalized Therapy, Vol. 31, Núm. 1, pp. 17-23
2015
-
High frequency and founder effect of the CYP3A4∗20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme
Pharmacogenomics Journal, Vol. 15, Núm. 3, pp. 288-292
2013
2008
-
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3
Nature Genetics, Vol. 40, Núm. 5, pp. 623-630
-
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer
Human Molecular Genetics, Vol. 17, Núm. 23, pp. 3720-3727